Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-24-000910

EXEC. VP AND CLO sold 3,395 shares at an average $28.85 ($97,960)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Boulding Mark Elliott EXEC. VP AND CLO 2024-01-08 Sale 10b5-1 −1,457 $28.64 $41,729 73,921 D
Boulding Mark Elliott EXEC. VP AND CLO 2024-01-09 Sale 10b5-1 −1,938 $29.01 $56,231 71,983 D
Open-market sales · 3,395 sh · avg $28.85 · $97,960
Loading xslF345X05/form4-01102024_090136.xml…